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Abstract Using a method involving repeated oxygen uptake
(MO2) determinations in skeletal muscle ex vivo, the addition of
leptin was found to increase MO2 in soleus muscles from lean
mice. These effects were found to be inhibited by phosphatid-
ylinositol 3-kinase inhibitors, absent in muscles from obese
Leprdb mice which have the dysfunctional long form of leptin
receptor, and blunted in muscles from diet-induced obese mice in
the fed state but not during fasting. These findings indicate that
leptin has direct thermogenic effects in skeletal muscle, and that
these effects require both the long form of leptin receptors and
phosphatidylinositol 3-kinase signalling. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
Key words: Leptin; Obesity; Diabetes ; Thermogenesis
1. Introduction
Leptin, a hormone encoded by the ob gene and produced
mainly by adipocytes [1], has been shown to play an impor-
tant role in the regulation of body weight via its e¡ects on
both food intake and energy expenditure [2]. Gene mutations
that lead either to a de¢ciency in the production of functional
leptin or to non-functional leptin receptors (OB-R) result in
hyperphagia and hypometabolism, both of which contribute
to obesity and insulin resistance [3]. In several animal models,
the administration of recombinant leptin results in improved
insulin sensitivity concomitant to weight losses which are
partly due to decreased food intake and partly to counteract-
ing the suppression of thermogenesis (i.e. energy conservation)
that occurs in response to the diminished energy intake [4^7].
The mechanisms by which leptin exerts its control over ther-
mogenesis are thought to involve its central e¡ects on hypo-
thalamic OB-R, leading to increased sympathetic out£ow [8].
Indeed, leptin administration has been shown to increase sym-
pathetic activation of brown adipose tissue thermogenesis [9],
an e¡ect that can be entirely abolished by surgical ablation of
this tissue’s sympathetic innervation [10]. Whether skeletal
muscle, which is considered to be quantitatively the most im-
portant tissue for dietary regulation of thermogenesis, is also a
site for leptin’s action on thermogenesis is unclear, particu-
larly given reports that central sympathetic out£ow to skeletal
muscle, as judged by norepinephrine turnover rates in individ-
ual muscles, is unresponsive to diet [11]. However, the facts
that skeletal muscle expresses OB-R [12] and that leptin is
now known to activate signal transduction directly in insu-
lin-sensitive organ/tissues [13,14] prompted us to investigate
whether leptin could exert direct control on thermogenesis
in skeletal muscle. To this end, the direct e¡ect of leptin on
skeletal muscle thermogenesis was evaluated by assessing
changes in metabolic rate of the soleus muscle ex vivo by a
method that involves repeated oxygen uptake determinations
in indirect microcalorimeter chambers. We investigated the
thermogenic responses to leptin in muscles from lean mice,
from mice which developed obesity because of mutations ei-
ther in the production of functional leptin or in leptin recep-
tors, as well as in mice which developed obesity when shifted
from chow to a high-fat energy-dense diet.
2. Materials and methods
2.1. Animals and diets
Several strains of mice were studied, all being males and aged 6^8
weeks. BALB/c mice were obtained from CMU, University of Geneva
(Switzerland), whereas ob/ob mice (C57BL/6OlaHsd-Lepob), db/db
mice (C57BL/KsOlaHsd-Leprdb) and their respective controls were
purchased from Harlan (Horst, The Netherlands). Prior to the start
of each experiment, the mice were adapted for at least 1 week to a
temperature-controlled room (22‡C) with a 12-h light/dark cycle. They
had free access to tap water, and were maintained on a commercial
pelleted laboratory diet (Provimi-Lacta, Cossonay, Switzerland) con-
sisting, by energy, of 24% protein, 66% carbohydrates, and 10% fat.
In the study of diet-induced obesity, BALB/c mice were fed for 10^17
days on a high-fat diet providing approximately 50% of energy from
lard, 25% from carbohydrates and 25% from protein; the control mice
were fed the low-fat chow diet. All diets contained minerals and vi-
tamins at levels recommended by the American Institute of Nutrition.
All animals used in the present studies were maintained in accordance
with our institute’s regulations and guide for the care and use of
laboratory animals.
2.2. Muscle tissue preparations
Each mouse was killed by decapitation between 8.30 and 9.00 h,
and their soleus muscles were carefully dissected out intact together
with their tendons and freed only of loosely attached connective tis-
sue. They were then placed on a stainless steel frame, at physiological
resting length, in the test chambers of twin indirect microcalorimeters
perifused with a Krebs^Ringer bicarbonate bu¡er of the following
composition (in mmol/l): 116.8 NaCl, 25 NaHCO3, 5.9 KCl, 1.2
MgSO4, 1.2 NaH2PO4, 1.25 CaCl2, and 5 glucose. The medium was
gassed continuously with a mixture of 95% O2 and 5% CO2 and was
maintained at a set temperature of 30 þ 0.2‡C. At the end of the
experiment, the muscles were weighed after removal of their tendons
and rapid blotting on ¢lter paper.
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2.3. Measurement of tissue respiration rate
The respiratory rate of skeletal muscle was measured by a method
involving repeated O2 uptake determinations [15], as described by
Barde et al. [16]. The O2 partial pressure (pO2) of a bubble-free liquid
phase enclosed in a thick-walled Lucite chamber was measured by a
Clark O2 electrode connected to a polarographic circuit, whose output
voltage is directly proportional to pO2. At 10-min intervals, a pump
partially exchanged the solution for a fresh one within 2 min. All
values for O2 uptake rate (MO2) were taken during steady-state res-
piration. For each drug, this corresponded to 90^120 min after drug
administration. The basal steady-state MO2 was taken 120^150 min
after placing the muscle preparations in the calorimeter chambers.
2.4. Chemicals and solutions
All chemicals were of analytical grade and were purchased from
Fluka (Buchs, Switzerland). Recombinant murine leptin was pur-
chased from Insight Biotechnology (Middlesex, UK), wortmannin
from Calbiochem (Lucerne, Switzerland) and LY294002 from Sigma
(St. Louis, MO, USA).
2.5. Statistics
The analysis of data on changes in MO2 in response to leptin was
performed either by paired t-test or by analysis of variance (ANOVA)
with repeated measures, using the statistical software STATISTIK (St.
Paul, MN, USA). Upon detection of signi¢cant increases by ANOVA,
post-hoc pairwise comparisons were conducted using Tukey’s test,
with the level of statistical signi¢cance taken as P6 0.05.
3. Results
3.1. Murine models with intact or mutated leptin receptors
The results of our ¢rst experiment, presented in Fig. 1a,
indicate that the addition of leptin, at 5 or 10 nM, resulted
in signi¢cant increases in MO2 above the baseline rate in
muscles from BALB/c mice, namely by 22% and 35%, respec-
tively. In subsequent experiments, we examined the extent to
which the thermogenic responsiveness to leptin might be al-
tered in Lepob and Leprdb mice, murine models which develop
obesity because of a speci¢c mutation leading either to the
production of non-functional leptin or to dysfunctional leptin
receptors, respectively. The results indicate that leptin was
e¡ective in increasing muscle MO2 to the same extent in
Lepob mice and in lean wildtypes, i.e. by about 20% above
baseline rates (Fig. 1b). The addition of leptin to muscles from
Leprdb mice, however, failed to increase MO2, and this con-
trasts with the 23% increase in MO2 obtained in muscles from
their lean wildtypes (Fig. 1c).
3.2. Pharmacological inhibition of phosphatidylinositol 3-kinase
(PI 3-kinase)
Following the above-mentioned experiments which suggest
that the direct thermogenic e¡ects of leptin in skeletal muscle
require intact leptin receptors, we investigated whether post-
receptor signalling by PI 3-kinase ^ which has been shown to
be required for other actions of leptin in many tissues or cell
systems ^ is also required for its direct thermogenic e¡ects in
the skeletal muscle. To this end, we utilized two known in-
hibitors of PI 3-kinases, at doses that we had previously found
to have no e¡ect on basal MO2 of the muscle (data not
shown). The subsequent addition of either wortmannin or
LY294002 completely abolished the leptin-induced increase
in muscle MO2 (Fig. 2), suggesting that PI 3-kinase is also
required for the direct action of leptin in stimulating skeletal
muscle thermogenesis.
3.3. Dietary manipulation
Given evidence that high fat feeding can contribute to the
development of obesity, not only by increasing energy intake
but also by decreasing thermogenesis [17,18], and the general
Fig. 1. Respiration rate (MO2) of skeletal muscle obtained (a) from
chow-fed lean BALB/c mice (n = 16), (b) from obese Lepob mice and
their lean wildtypes, wt(n = 5), and (c) from obese Leprdb mice and
their lean wildtypes (n = 5). Data are means, with vertical bars rep-
resenting S.E.M. Signi¢cant e¡ects of leptin in increasing MO2,
shown as dark areas above basal rates, were assessed either by
paired t-test or by ANOVA with repeated measures. Following AN-
OVA, post-hoc pairwise comparisons were made by Tukey’s test,
and values not sharing the same superscript (a, b, c) are signi¢-
cantly di¡erent from each other (P6 0.05); n.s. = no signi¢cant dif-
ference.
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associations between dietary-induced obesity, hyperleptinemia
and leptin resistance [3], we investigated whether the thermo-
genic e¡ect of leptin in muscles from mice made obese by high
fat feeding for about 2 weeks could be impaired. The results,
shown in Fig. 3a, indicate that the addition of leptin failed to
stimulate MO2 in muscles from these diet-induced obese
(DIO) mice; by contrast, muscles from their age-matched con-
trol mice fed chow showed a 26% increase in MO2 following
the addition of leptin. To test whether the lack of thermogenic
response to leptin in muscles from DIO mice could be re-
versed by caloric restriction, a state of hypoleptinemia, anoth-
er experiment assessed the thermogenic e¡ect of leptin in
muscles from DIO mice fasted for 36 h. The results, presented
in Fig. 3b, con¢rm our above-mentioned ¢ndings about the
absence of leptin-induced increase in MO2 in muscle from
DIO mice, and also indicate that leptin was e¡ective in sig-
ni¢cantly increasing MO2 in muscle from DIO mice after
prior fasting.
4. Discussion
Over much of the past century, the skeletal muscle, by
virtue of its large size contributing 30^40% of body mass,
has been considered the major tissue that enables mammals
to adapt to changes in food availability by turning down the
rate of heat production during periods of food scarcity so as
to conserve energy, or by turning it up during food abundance
so as to burn excess food energy. However, the mechanisms
by which skeletal muscle could allow such adaptations remain
elusive, in part because of practical di⁄culties in studying
metabolism in intact muscles. Using a method involving re-
peated oxygen consumption determinations in the whole
muscle ex vivo, we report here that leptin, a hormone whose
role in the control of whole-body thermogenesis has so far
focused on its e¡ect on brain centers that activate the sym-
pathetic nervous system, also stimulates thermogenesis by its
direct e¡ects on leptin receptors in the skeletal muscle. We
also demonstrate that this peripheral e¡ect of leptin on ther-
mogenesis, which requires PI 3-kinase activity, is blunted in
muscles from mice made obese by feeding an energy-dense
Fig. 2. Respiration rate (MO2) of skeletal muscles from ad libitum
fed BALB/c mice in response to leptin, and the e¡ect of subsequent
administration of (a) wortmannin or (b) LY294002, two pharmaco-
logical inhibitors of PI 3-kinase. All data are means, with vertical
bars representing S.E.M. (n = 5^6). The signi¢cant e¡ects of leptin
in increasing MO2 (shown as dark areas above basal rates) and
their inhibition by subsequent addition of wortmannin or LY294002
were assessed by ANOVA with repeated measures. Following AN-
OVA, post-hoc pairwise comparisons were made by Tukey’s test,
and values not sharing the same superscript (a, b) are signi¢cantly
di¡erent from each other (P6 0.05).
Fig. 3. Respiration rate (MO2) of skeletal muscles obtained (a) from
BALB/c mice fed ad libitum on either a low-fat chow diet or a
high-fat diet (DIO mice) for a period of 10^17 days; the percentage
body fat in the dietary-induced obese (DIO) mice was signi¢cantly
higher than that in the chow-fed controls (16.9% versus 7.9%;
P6 0.01), (b) from DIO mice fed ad libitum or fasted for 36 h. All
data are means, with vertical bars representing S.E.M. (n = 5^6). Sig-
ni¢cant e¡ects of leptin in increasing MO2, shown as dark areas
above basal rates, were assessed by paired t-test; n.s. = no signi¢cant
di¡erence.
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high-fat diet, but reversed by caloric restriction. Furthermore,
the ¢nding here that the thermogenic responsiveness to leptin
is unimpaired in muscles from obese Lepob mice which are
de¢cient in functional leptin raises the possibility that the
direct e¡ect of leptin on skeletal muscle thermogenesis may
have contributed to the reversal of obesity in this mutant
following chronic leptin replacement therapy.
It is known that alternative splicing of the leptin receptor
(OB-R) gene provides several OB-R mRNA isoforms that
encode receptors that di¡er in the length of their intracellular
domains and that are expressed in multiple tissues at varying
amounts [12]. The OB-R isoform with a long intracellular
domain (OB-Rb) is highly expressed in the hypothalamus,
and its activation leads to PI 3-kinase signalling [3]. This iso-
form is also expressed, albeit at lower levels, in skeletal muscle
and several other peripheral tissues [12,13]. The present study
also shows that both the intact OB-Rb and PI 3-kinase activ-
ity are required for the direct e¡ect of leptin on skeletal
muscle thermogenesis. Indeed, the increase in muscle MO2
in response to leptin is abolished in the presence of PI 3-ki-
nase inhibitors, wortmannin or LY294002, and absent in
muscles from Leprdb mice which are characterized by a muta-
tion leading to dysfunctional OB-Rb signalling. These results
raise questions as to whether in skeletal muscles from mice
made obese by high fat feeding, the blunted thermogenic re-
sponse to leptin in the fed state, which is reversed by fasting,
occurs by a reversible desensitization of the OB-Rb signalling
pathway or is dependent upon inactivation of the ¢nal e¡ector
mechanisms. Whatever the answer, our data provide evidence
that leptin has the potential to exert direct control over skel-
etal muscle thermogenesis by activating the OB-Rb pathway
in the fed state or during caloric restriction. During starvation
therefore, the prompt and drastic fall in circulating leptin
would lead to energy conservation not only by the withdrawal
of its central actions on sympathetically mediated thermogen-
esis in tissues with a high speci¢c metabolic rate such as
brown adipose tissue, liver, heart and kidneys, but also by
removal of its direct peripheral action on skeletal muscle ther-
mogenesis.
The skeletal muscle is a major tissue contributing not only
to metabolic rate and thermogenesis but also accounting for a
large proportion of glucose utilization and whole-body lipid
oxidation. Comparison of our data on the direct e¡ects of
leptin in stimulating skeletal muscle thermogenesis with those
previously reported about the direct e¡ects of leptin in alter-
ing muscle substrate metabolism [19] ^ i.e. increased glucose
uptake and fatty acid oxidation at the expense of storage as
triglycerides ^ shows striking similarities concerning PI 3-ki-
nase requirement and in the blunting of the muscle response
in animals made obese by high fat feeding [20^22]. These
¢ndings suggest that, in the skeletal muscle, the mechanisms
by which leptin a¡ects substrate metabolism and thermogen-
esis are interdependent. In this context, the question arises as
to whether stimulation of AMP-activated protein kinase,
which has recently been shown to be a principal mediator of
the e¡ects of leptin on fatty acid oxidation [23], is also re-
quired together with PI 3-kinase signalling for its direct ther-
mogenic e¡ect in skeletal muscle. Since the development of
obesity and insulin resistance are associated with decreased
lipid oxidation and increased concentration of intramuscular
triglycerides, one could entertain the possibility that impaired
skeletal muscle thermogenesis to leptin, as observed here dur-
ing the development of diet-induced obesity in mice, may be a
primary event which then leads to impairments in substrate
metabolism and in insulin resistance.
With evidence in humans implicating a low capacity for
diet-induced thermogenesis [24] and marginal leptin de¢ciency
[25] as risk factors for obesity and insulin resistance, our
studies provide the impetus for the elucidation of molecular
pathways by which leptin exerts direct control on skeletal
muscle thermogenesis. Furthermore, it remains to be estab-
lished whether the direct e¡ect of leptin on skeletal muscle
thermogenesis is essentially endocrine, paracrine with leptin
being secreted from adipocytes in close vicinity to muscles
or indeed autocrine as suggested by evidence for nutritionally
regulated leptin gene expression in skeletal muscle [26].
Although the increase in metabolic rate (20^35%) due to the
direct e¡ect of leptin on muscle may not, a priori, be consid-
ered to be large, it must be emphasized that in terms of overall
impact on whole-body energy expenditure, leptin-induced
thermogenesis in skeletal muscle could be considerable by
virtue of the total proportion of body mass attributable to
muscle. From a therapeutic standpoint therefore, our demon-
stration of a direct e¡ect of leptin on skeletal muscle to acti-
vate thermogenesis provides the rationale for the development
of peripherally acting anti-obesity drugs that will selectively
target leptin signalling in a tissue which is viewed as the major
site for impairments in the dissipation of excess fat to heat.
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